Rockland Trust Co. acquired a new stake in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) in the 3rd quarter, HoldingsChannel reports. The firm acquired 2,640 shares of the semiconductor company’s stock, valued at approximately $353,000.
A number of other institutional investors have also modified their holdings of the stock. IMG Wealth Management Inc. acquired a new position in shares of Lam Research during the second quarter worth about $26,000. Howard Hughes Medical Institute purchased a new position in shares of Lam Research during the 2nd quarter worth approximately $27,000. Sound Income Strategies LLC acquired a new stake in shares of Lam Research in the 3rd quarter valued at approximately $41,000. Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research in the second quarter valued at approximately $29,000. Finally, Tripletail Wealth Management LLC acquired a new position in Lam Research during the third quarter worth $44,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Multiple analyst upgrades and higher price targets reinforce upside expectations (Sanford C. Bernstein raised its target to $285; other outlets bumped targets to the mid‑$200s), supporting investor confidence. Bernstein Adjusts Price Target on Lam Research
- Positive Sentiment: Industry and fundamentals view: commentary highlights strong AI/memory-driven demand, solid margins and $5B‑plus quarter potential — arguments used to justify a premium multiple. High P/E: Justified Premium or Too Pricey?
- Neutral Sentiment: Technical signal: LRCX recently crossed above its 20‑day moving average, which can attract momentum traders but is a short‑term indicator. 20-Day Moving Average Crossover
- Negative Sentiment: Insider selling: Director Eric Brandt sold 35,000 shares (~$7.9M), trimming his stake — a signal that can trigger short‑term investor caution even if not unusual for insiders to diversify. Director Sells 35,000 Shares
- Negative Sentiment: Leadership/strategic concern: reporting on a leadership shift and the CEA‑Leti alliance prompted questions about whether recent multiple expansion is fully justified, creating valuation uncertainty for some investors. Leadership Shift And CEA Leti Alliance
- Negative Sentiment: Options flow: unusually large put buying (roughly +112% vs. average) indicates elevated hedging or bearish positioning, which can amplify downside pressure in the near term.
Lam Research Stock Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter last year, the business earned $0.91 EPS. Lam Research’s revenue for the quarter was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.
Lam Research Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Wednesday, March 4th. Lam Research’s payout ratio is currently 21.31%.
Wall Street Analysts Forecast Growth
LRCX has been the topic of a number of recent analyst reports. Evercore set a $275.00 price target on shares of Lam Research in a research note on Thursday, January 29th. JPMorgan Chase & Co. increased their target price on shares of Lam Research from $165.00 to $300.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Cantor Fitzgerald reissued an “overweight” rating and set a $320.00 price target (up previously from $265.00) on shares of Lam Research in a research note on Thursday, January 29th. Dbs Bank lifted their price objective on Lam Research from $119.40 to $184.20 in a report on Monday, October 27th. Finally, Wells Fargo & Company upped their target price on Lam Research from $250.00 to $290.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $244.88.
Check Out Our Latest Stock Report on Lam Research
Insider Activity
In other news, Director Eric Brandt sold 35,000 shares of the stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director owned 253,705 shares in the company, valued at approximately $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.31% of the stock is owned by corporate insiders.
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More
- Five stocks we like better than Lam Research
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
